CHRS

CHRS Other Income/Expenses (Net)

-$4.55MTTM · USD

Period ending:

CHRS FY Other Income/Expenses (Net)USD
CHRS FY Other Income/Expenses (Net)2012-12-31: $5.50M2013-12-31: -$17.64M2014-12-31: -$22.50M2015-12-31: -$4.87M2016-12-31: -$11.86M2017-12-31: -$6.15M2018-12-31: -$4.99M2019-12-31: -$14.99M2020-12-31: -$20.61M2021-12-31: -$23.24M2022-12-31: -$34.87M2023-12-31: -$35.07M2024-12-31: $140.17M2025-12-31: -$3.59M$140.17M-$35.07M
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CHRS other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Coherus Oncology Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-3,590,000
140,174,000
-35,073,000
-34,874,000
-23,242,000
-20,612,000
-14,993,000
-4,993,000
-6,150,000
-11,857,000
-4,871,000
-22,495,000
-17,642,000
5,500,000

Compare other income/expenses (net)

All CHRS financial metrics · CHRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.